ChiCTR2200064636 版本V1.1 版本创建时间2022/10/13 12:01:38 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2200064636 

最近更新日期:

Date of Last Refreshed on:

2022-10-13 12:00:59 

注册时间:

Date of Registration:

2022-10-13 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

终末期肿瘤患者主要照护者品味能力现状及其对正性情绪的干预效果研究

Public title:

Current status of taste ability of primary caregivers of end-stage cancer patients and its intervention effect on positive emotion

注册题目简写:

English Acronym:

研究课题的正式科学名称:

终末期肿瘤患者主要照护者品味能力现状及其对正性情绪的干预效果研究

Scientific title:

Current status of taste ability of primary caregivers of end-stage cancer patients and its intervention effect on positive emotion

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

张梅 

研究负责人:

姚桂英 

Applicant:

Zhang Mei 

Study leader:

Yao Gui Ying 

申请注册联系人电话:

Applicant telephone:

17335771086

研究负责人电话:

Study leader's
telephone:

18039975287

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

845104793@qq.com

研究负责人电子邮件:

Study leader's E-mail:

845104793@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

河南省郑州市郑东新区

研究负责人通讯地址:

河南省郑州市郑东新区

Applicant address:

Zhengzhou New District, Zhengzhou City, Henan Province

Study leader's address:

Zhengzhou New District, Zhengzhou City, Henan Province

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

新乡医学院

Applicant's institution:

xinxiang medical university

研究负责人所在单位:

新乡医学院

Affiliation of the Leader:

xinxiang medical university

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

XYLL-20220210

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

新乡医学院伦理委员会

Name of the ethic committee:

Ethics Committee of Xinxiang Medical university

伦理委员会批准日期:

Date of approved by ethic committee:

2022-07-20 00:00:00

伦理委员会联系人:

刘老师

Contact Name of the ethic committee:

liu lao shi

伦理委员会联系地址:

河南省新乡市红旗区金穗大道601号

Contact Address of the ethic committee:

601 Jinsui Avenue, Hongqi District, Xinxiang City, Henan Province, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

新乡医学院

Primary sponsor:

xinxiang medical university

研究实施负责(组长)单位地址:

河南省新乡市红旗区金穗大道601号

Primary sponsor's address:

601 Jinsui Dadao, Hongqi District, Xinxiang City, Henan Province, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

河南

市(区县):

新乡

Country:

China

Province:

Henan province

City:

Xinxiang

单位(医院):

新乡市中心医院

具体地址:

河南省新乡市金穗大道56号

Institution
hospital:

Xinxiang Central Hospital

Address:

56 Jinsui Avenue, Hongqi District, Xinxiang, Henan

经费或物资来源:

新乡医学院

Source(s) of funding:

xinxiang medical university

研究疾病:

晚期癌症的主要照顾者的情绪  

Target disease:

The emotions of a primary caregiver with advanced cancer

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

I期临床试验 

Study phase:

1

研究设计:

单臂 

Study design:

Single arm 

研究目的:

探索品味技术对终末期癌症主要照护者正性情绪的促进效果。  

Objectives of Study:

To explore the promoting effect of taste technology on positive emotions of primary caregivers of end-stage cancer.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

①符合终末期癌症患者(均经病理学或组织细胞学确诊为癌症,TNM 分期为Ⅲ、Ⅳ期,或存在远处转移;预计生存周期≥6个月)的主要照顾者;
②是患者的父母、子女、配偶、亲友等;
③每天照顾时间≥8h 者,并累计≥1个月者;
③年龄≥18周岁,≤65周岁者;
④有良好沟通及表达能力;
⑤对本研究知情同意且自愿参与。

Inclusion criteria

①Patients with end-stage cancer (all patients were diagnosed with cancer by pathology or histopathology, TNM stage ⅲ and ⅳ, or distant metastasis; Expected life span ≥6 months);
② is the patient's parents, children, spouse, relatives and friends;
③ Care time ≥8h per day, and accumulated ≥1 month;
③ Persons aged ≥18 and ≤65;
(4) Good communication and expression skills;
⑤ Informed consent and voluntary participation in this study.

排除标准:

①领取报酬者;②合并心肌梗死、心力衰竭等严重影响心理健康和生活质量的疾病;③既往有精神病史;④近期(≤2个月)发生离异、丧亲等生活事件者;⑤既往接受过心理干预,可能影响调查结果者。

Exclusion criteria:

① Remunerator; ② Complicated with myocardial infarction, heart failure and other diseases that seriously affect mental health and quality of life; ③ Have a history of mental illness; (4) recently (≤2 months) have been divorced, bereavement and other life events; ⑤ Those who have received psychological intervention in the past may affect the survey results.

研究实施时间:

Study execute time:

From 2022-10-10 00:00:00 To 2023-11-30 00:00:00  

征募观察对象时间:

Recruiting time:

From 2022-10-01 00:00:00 To 2023-11-30 00:00:00

干预措施:

Interventions:

组别:

干预组

样本量:

43

Group:

Intervention group

Sample size:

干预措施:

品味团体心理辅导

干预措施代码:

Intervention:

Taste group counseling

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

河南 

市(区县):

新乡 

Country:

China

Province:

Henan

City:

Xinxiang

单位(医院):

新乡市中心医院 

单位级别:

三甲 

Institution
hospital:

Xinxiang Central Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

正性情绪

指标类型:

主要指标

Outcome:

Positive emotions

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

皮电波

组织:

Sample Name:

Brain waves

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

使用随机数字表法

Randomization Procedure (please state who generates the random number sequence and by what method):

Use the random number table method

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

未开始

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

未开始

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

未开始

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

未开始

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2022-10-13 12:00:50